At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4599 Weight Loss Drugs
Closed Christmas Day 12-24 13:00:00 EST
1,505.76
+10.06
+0.67%
High1,516.49Low1,496.24Vol44.89M
Open1,496.24D1 Closing1,495.70Amplitude1.35%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O2.91BT/O Rate--Tradable Shares0.00
P/B9.867498ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Bollywood Stars and 40% Price Cuts: Eli Lilly and Novo Nordisk Battle for India's Weight-Loss Drug Market
Deep News  ·  08:19
Bollywood Stars and 40% Price Cuts: Eli Lilly and Novo Nordisk Battle for India's Weight-Loss Drug Market
Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval
Benzinga  ·  01:31
Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval
Pfizer Receives Tax Demand Order Worth 12.7 Million Rupees
Reuters  ·  12-24 21:07
Pfizer Receives Tax Demand Order Worth 12.7 Million Rupees
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Wednesday; AST SpaceMobile, Novo Nordisk to Advance
MT Newswires Live  ·  12-24 19:31
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Wednesday; AST SpaceMobile, Novo Nordisk to Advance
Telescope Innovations posts FY 2025 expenses of CAD 7.3 million, up 26 percent
Reuters  ·  12-24 07:36
Telescope Innovations posts FY 2025 expenses of CAD 7.3 million, up 26 percent
Pfizer Inc. Stock Underperforms Tuesday When Compared To Competitors
Dow Jones  ·  12-24 05:38
Pfizer Inc. Stock Underperforms Tuesday When Compared To Competitors
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
Benzinga_recent_news  ·  12-24 03:04
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
Silver Breaks Above $70, Novo Nordisk Soars 9% On Obesity Pill Approval: What's Moving Markets Wednesday?
Benzinga_recent_news  ·  12-24 02:18
Silver Breaks Above $70, Novo Nordisk Soars 9% On Obesity Pill Approval: What's Moving Markets Wednesday?
What's Going On With Eli Lilly Stock Today?
Benzinga_recent_news  ·  12-24 01:25
What's Going On With Eli Lilly Stock Today?
Nordic Shares Rise; Novo Nordisk Series B Climbs Highest
Dow Jones  ·  12-24 01:06
Nordic Shares Rise; Novo Nordisk Series B Climbs Highest
Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus
Benzinga_recent_news  ·  12-24 01:06
Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus
Pfizer says patient dies after receiving hemophilia drug in trial
Reuters  ·  12-24 00:20
Pfizer says patient dies after receiving hemophilia drug in trial
BUZZ-U.S. STOCKS ON THE MOVE-Invivyd, US natgas companies, New Era Energy
Reuters  ·  12-24 00:20
BUZZ-U.S. STOCKS ON THE MOVE-Invivyd, US natgas companies, New Era Energy
BRIEF-Participant Death Reported in Pfizer Hemophilia Trial, Letter Shows
Reuters  ·  12-24 00:17
BRIEF-Participant Death Reported in Pfizer Hemophilia Trial, Letter Shows
BRIEF-Pfizer Says Does Not Anticipate Any Impact To Safety For Patients Treated With Approved Marstacimab
Reuters  ·  12-24 00:05
BRIEF-Pfizer Says Does Not Anticipate Any Impact To Safety For Patients Treated With Approved Marstacimab
Pfizer: Participant in Long-Term Extension Trial Studying Marstacimab in People Living With Hemophilia a/B With/Without Inhibitors Passed Away in Dec
THOMSON REUTERS  ·  12-24 00:03
Pfizer: Participant in Long-Term Extension Trial Studying Marstacimab in People Living With Hemophilia a/B With/Without Inhibitors Passed Away in Dec
Pfizer: Safety and Well-Being of Participants in Our Clinical Trials Remain Our Highest Priority, and We Are Committed to Transparency
THOMSON REUTERS  ·  12-23 23:55
Pfizer: Safety and Well-Being of Participants in Our Clinical Trials Remain Our Highest Priority, and We Are Committed to Transparency
Pfizer: Does Not Anticipate Any Impact to Safety for Patients Treated With Approved Marstacimab
THOMSON REUTERS  ·  12-23 23:55
Pfizer: Does Not Anticipate Any Impact to Safety for Patients Treated With Approved Marstacimab
Novo Nordisk Up Nearly 10%, on Pace for Largest Percent Increase Since August 2023 -- Data Talk
Dow Jones  ·  12-23 23:03
Novo Nordisk Up Nearly 10%, on Pace for Largest Percent Increase Since August 2023 -- Data Talk
Eli Lilly Shares Reverse Premarket Course, Last up 1%
THOMSON REUTERS  ·  12-23 22:40
Eli Lilly Shares Reverse Premarket Course, Last up 1%

Introduction

Company Name.
BK4599
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--